Third-party lab testing: 14 independent Janoshik assays on file, covering 14 substances, median measured purity 99.6%, most recent test 2026-01-22.
| Substance | Measured purity | Test date |
|---|---|---|
| Retatrutide 20mg | 99.82% | 2026-01-22 |
| Retatrutide 10mg | 99.63% | 2026-01-22 |
| Bpc157 5mg | 99.72% | 2026-01-02 |
| Mots-c 40mg | 99.85% | 2025-12-31 |
| Mots-c 10mg | 99.72% | 2025-12-31 |
| Tb500 10mg | 99.54% | 2025-12-31 |
| Tb500 5mg | 99.62% | 2025-12-31 |
| Tirzepatide 100mg | 99.90% | 2025-12-31 |
| Tirzepatide 60mg | 99.95% | 2025-12-31 |
| Survodutide 10mg | 99.45% | 2025-09-01 |
| Ace-031 1mg | 99.24% | 2025-09-01 |
| HGH 15iu | 92.10% | 2025-09-01 |
| HGH 10iu | 97.38% | 2025-09-01 |
| HCG 5000iu | not reported | 2025-09-01 |
13 of these 14 assays report a measured purity figure. The other 1 confirm the substance was submitted and tested but carry no purity number on the certificate, which is not the same as a failed result.